abstract |
C:\NRPortl M T 6351.. DOC-1/10/2012 The present invention provides a method for the treatment of a hepatitis C virus infection in a host, the method comprising administering to the host an effective amount of a purine or pyrimidine p-D-2'-methyl-ribofuranosyl nucleoside or a stabilized phosphate prodrug thereof. |